Abstract

BackgroundWe report the clinical activity and safety of bintrafusp alfa, a first-in-class bifunctional fusion protein composed of the extracellular domain of the transforming growth factor β (TGF-β)RII receptor (a TGF-β...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Long-term follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck (SCCHN).
Byoung Chul Cho ... Edward Francis Mcclay
Journal of Clinical Oncology | VOL. 39
Byoung Chul Cho, et. al.Byoung Chul Cho ... Edward Francis Mcclay
20 May 2021
Data from Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer
Toshihiko Doi ... Christoph Helwig
-
Toshihiko Doi, et. al.Toshihiko Doi ... Christoph Helwig
31 Mar 2023
Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer.
Yoon-Koo Kang ... Motonobu Osada
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 26
Yoon-Koo Kang, et. al.Yoon-Koo Kang ... Motonobu Osada
01 Jul 2020
Data from Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer
Christoph Helwig ... Yung-Jue Bang
-
Christoph Helwig, et. al.Christoph Helwig ... Yung-Jue Bang
31 Mar 2023
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Tumor cell-released autophagosomes (TRAPs) induce PD-L1-decorated NETs that suppress T-cell function to promote breast cancer pulmonary metastasis
Xiaohe Zhou ... Li-Xin Wang
Journal for ImmunoTherapy of Cancer | VOL. 12
Xiaohe Zhou, et. al.Xiaohe Zhou ... Li-Xin Wang
26 Jun 2024
Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study
Yu-Qi Wang ... Xin-Gang Cui
Journal for ImmunoTherapy of Cancer | VOL. 12
Yu-Qi Wang, et. al.Yu-Qi Wang ... Xin-Gang Cui
21 Jun 2024
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
Michele Iuliani ... Francesco Pantano
Journal for ImmunoTherapy of Cancer | VOL. 12
Michele Iuliani, et. al.Michele Iuliani ... Francesco Pantano
21 Jun 2024
Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma
Lianjun Zhao ... Zhengyun Zou
Journal for ImmunoTherapy of Cancer | VOL. 12
Lianjun Zhao, et. al.Lianjun Zhao ... Zhengyun Zou
21 Jun 2024
View more papers